Paul, Weiss, Rifkind, Wharton & Garrison LLP

New York, NY Professional servicesNAICS 541110

Self-funded health planPlan year 2025Renews January
2,090Participants+2% vs. prior year
$5.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#18 of 70Professional services in NYBy participants

Overview

Paul, Weiss, Rifkind, Wharton & Garrison LLP sponsors a self-funded health plan that covered 2,090 participants in plan year 2025, up 2% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,090 · prior year 2,042
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Paul, Weiss, Rifkind, Wharton & Garrison Before Tax PR & Healthcare FL SP, plan 506 (2,090 participants)
Broker compensation
$1.2M across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
First Unum Life Insurance CompanyShort-term disability, Long-term disability4,124$3.5M$149K
Delta Dental of New YorkDental, HMO, PPO3,161$1.9M$94K
Provident Life and Casualty Insurance CompanyShort-term disability, Long-term disability792$1.8M$487K
Underwriters at Lloyd'sShort-term disability, Long-term disability97$1.2M$228K
Prudential Insurance Company of AmericaLife2,027$1.0M$51K
Provident Life and Casualty Insurance CompShort-term disability, Long-term disability95$219K$70K
Vision Service PlanVision1,516$216K$4K
Zurich American Insurance CompanyAccidental Death and Dismemberment2,764$38K$6K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$5.0M/ year

Estimated prescription spend: 2,090 participants × $2,371 national average per member. Usually higher once dependents are counted.

$129K–$318K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$38K–$94K
Lower-cost therapeutic alternatives$55K–$115K
Generic pricing vs. actual cost$24K–$71K
PBM contract terms$12K–$37K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Paul, Weiss, Rifkind, Wharton & Garrison LLP
Sponsor EIN
13-1662105
Plan number
506
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-1662105 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Paul Weiss Rifkind Wharton & Garrison LLP Cash Or Deferred Plan
Type
401(k) plan
Participants
3,971

About this data

Source: Paul, Weiss, Rifkind, Wharton & Garrison LLP's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Paul, Weiss, Rifkind, Wharton & Garrison LLP.

Request a correction · Methodology